Cited by — In primary membranous nephropathy, obinutuzumab increased the likelihood of complete remission vs. tacrolimus at 104 wk | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite In primary membranous nephropathy, obinutuzumab increased the likelihood of complete remission vs. tacrolimus at 104 wk.
No admitted local citation edges point to this work yet.
